Therapeutic potential of anti-oxidants and diabetic retinopathy

Bibliography

• ENGERMAN RL, DAVIS MD, BLOODWORTH JMB, JR: Retinopathy in experimental diabetes: its relevance to diabetic retinopathy in man. In Diabetes, Proc VII Congr Int Diab Fed. Rodriguez R, Vallance-Owen J, (Eds.) Excerpta Medica, The Netherlands (1971):261–267.
   Google Scholar
• FORRESTER JV, KNOTT RIVI: Pathogenesis of diabetic retinopathy and cataract. In: Pathogenesis of Diabetic Retirropathy and Cataract Blackwell Sciences, UK (1997):45.1-45.17.
   Google Scholar
• FRANK RN: Diabetic retinopathy. In: Diabetic Retirropathy. Elsevier Science Ltd., UK (1995):361–392.
   Google Scholar
• KUWABARA T, COGAN DG: Studies of retinal vascular patterns: I. Normal architecture. Arch. Ophthalmol (1960) 64:904–911.
   PubMed Web of Science ®Google Scholar
• KOHNER EM, PATEL V, RASSAM SM:Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes (1995) 44:603–607.
   PubMed Web of Science ®Google Scholar
• BURSELL SE, CLERMONT AC, AIELLOLP et al.: High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care (1999) 22:1245–1251.
   PubMed Web of Science ®Google Scholar
• PRYOR WA: Vitamin E and heart disease: basic science to clinical intervention trials. Free Rad. Biol. Med. (2000) 28:141–164.
   PubMed Web of Science ®Google Scholar
• SEN CK, KHANNA S, ROY S, PACKER L: Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-src) kinase activation and death of ht4 neuronal cells. j. Biol. Chem. (2000) 275:13049–13055.
   Google Scholar
• DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Eng] J. Med. (1993) 329:977–986.
   PubMed Web of Science ®Google Scholar
• ••Advantage of long-term intensive controlof blood sugar on the development of complications in insulin dependent diabetic patients.
   Google Scholar
• UKPDS: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet (1998) 352:837–853.
   PubMed Web of Science ®Google Scholar
• ••Advantage of intensive control of blood sugar on the development of complications in non-insulin dependent diabetic patients.
   Google Scholar
• DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: Early worsening of diabetic retinopathy in the diabetes control and complication trial. Arch. Ophthalm. (1998) 116:874–886.
   PubMed Web of Science ®Google Scholar
• ENGERMAN RL, KERN TS: Progression of incipient diabetic retinopathy during good glycemic control. Diabetes (1987) 36:808–812.
   PubMed Web of Science ®Google Scholar
• HAMMES H-P, KLINZING I, WIEGAND S, BRETZEL RG, COHEN AM, FEDERLIN K: Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen diabetic rat. Invest. Ophrhalmol. Vis. Sci. (1993) 34:2092–2096.
   PubMed Web of Science ®Google Scholar
• ROBISON WG, JACOT JL, GLOVER JP, BASSO MD, HOHMAN TC: Diabetic-like retinopathy: Early and late intervention therapies in galactose-fed rats. Invest. Ophrhalmol. Vis. Sci. (1998) 39:1933–1941.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG D, ABDELLA N, SALMAN A, MILLER N, RAHMAN EA, BOJANCYZK M: Relationship of lipid peroxides to diabetic complications. j Diab. Comp. (1992) 6:116–122.
   Google Scholar
• •Study presenting data that in non-insulin dependent diabetic patients, lipid peroxides correlate with the development of retinal complications.
   Google Scholar
• KOWLURU RA, KERN TS, ENGERMAN RL: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Rad. Biol. Med. (1996) 22:587–592.
   Web of Science ®Google Scholar
• •Diabetic animal study showing impairment of retinal antioxidant defense system.
   Google Scholar
• KOWLURU RA, TANG J, KERN TS: Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes (2001) 50:1938–1942.
   Google Scholar
• ••The first long-term animal studypresenting the beneficial effects of administration of antioxidants on the development of retinopathy in diabetic rats.
   Google Scholar
• STITT AW, M LY, GARDINER TA, BUCALA R, ARCHER DB, VLASSARA H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am. j Pathol (1997) 150:523–531.
   PubMed Web of Science ®Google Scholar
• KADOR PF, AKAGI Y, TAKAHASHI Y, IKEBE H, WYMAN M, KINOSHITA JH: Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch. Ophthalmol (1990) 108:1301–1309.
   PubMed Web of Science ®Google Scholar
• XIA P, INOGUCHI T, KERN TS, ENGERMAN RL, OATES PJ, KING GL: Characterization of the mechanism for the chronic activation of DAG-PKC pathway in diabetes and hypergalactosemia. Diabetes (1994) 43:1122–1129.
   PubMed Web of Science ®Google Scholar
• KOWLURU RA, JIROUSEK MR, STRAMM LE, FARID NA, ENGERMAN RL, KERN TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V Relationship between protein kinase C and ATPases. Diabetes (1998) 47:464–469.
   Google Scholar
• AIELLO LP, WONG JS: Role of vascularendothelial growth factor in diabetic vascular complications. Kidney Int. (2000) 77:S113–S119.
   Google Scholar
• BAYNES JW: Role of oxidative stress in development of complications in diabetes. Diabetes (1991) 40:405–412.
   PubMed Web of Science ®Google Scholar
• ••Review with the overall role of oxidative stress in the development of diabetic complications.
   Google Scholar
• CAMERON NE, COTTER MA, ARCHIBALD V: Chronic N-acetyl-L-cysteine treatment prevents impaired endothelium-dependent relaxation and improves peripheral nerve blood flow and conduction in diabetic rats. Eur. Invest. (1995) 25:A9.
   PubMed Web of Science ®Google Scholar
• DAI S, MCNEILL JH: Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozotocin-diabetic rats. Diabetes Res. OM Practice (1995) 27:11–18.
   PubMed Web of Science ®Google Scholar
• BAYNES JW, THROPE SR: Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes (1999) 48:1–9.
   PubMed Web of Science ®Google Scholar
• •Emphasis on the mechanisms of oxidative stress and carbonyl stress in diabetes.
   Google Scholar
• WOHAIEB SA, GODIN DV: Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes. Diabetes (1987) 36:1014–1018.
   PubMed Web of Science ®Google Scholar
• KADOYA K: Lipoperoxide levels and scavenging enzyme activities in the diabetic albino rabbit retina. _J. Japan Ophtlunal. Soc. (1990) 85:646–655.
   Google Scholar
• HALLIWELL B, GUTTERIDGE JMC: Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet (1984) 1:1396–1397.
   PubMed Web of Science ®Google Scholar
• JAIN SK: Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. I Biol. Chem. (1989) 264:21340–21345.
   Web of Science ®Google Scholar
• MURAKAMI K, KONDO T, OHTSUKA Y, FUJI WARA Y, SHIMADA M, KAWAKAMI Y: Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism (1989) 38:753–758.
   PubMed Web of Science ®Google Scholar
• ANDERSON RE, RAPP LM, WIEGAND RD: Lipid peroxidation and retinal degeneration. Curr. Eye Res. (1984) 3:223–227.
   PubMed Web of Science ®Google Scholar
• CASTORINA C, CAMPISI A, DI GIACOMO C, SORRENTI V, RUSSO A, VANELLA A: Lipid peroxidation and antioxidant enzymatic systems in rat retina as a function of age. Neurochem. Res. (1992) 17:599–604.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG D, AL-AWADI F: Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Rad. Biol. Med. (1991) 11:433–436.
   PubMed Web of Science ®Google Scholar
• •Relationship between lipid peroxidation and retinopathy in diabetic rats.
   Google Scholar
• LI W, YANOFF M, JIAN B, HE Z: Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cell Mal Biol. (1999) 45:59–66.
   PubMed Web of Science ®Google Scholar
• ROBISON WG, JACOT JL, KATZ ML, GLOVER JP: Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. I arid Pharmacy]. Ther. (2000) 16:109–120.
   Web of Science ®Google Scholar
• KOWLURU R, KERN TS, ENGERMAN RL: Abnormalities of retinal metabolism in diabetes or galactosemia II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr. Eye Res. (1994) 13:891–896.
   Google Scholar
• OBROSOVA IG, FATHALLAH L, GREENE DA: Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-alpha-lipoic acid. Eurj Pharmacy]. (2000) 398:139–146.
   PubMed Web of Science ®Google Scholar
• KOWLURU RA, ENGERMAN RL, KERN TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. Free Rad. Biol. Med. (1999) 26:371–378.
   Google Scholar
• WINKLER BS, DESANTIS N, SOLOMON F: Multiple NADPH-producing pathways control glutathione (GSH) content in retina. Exp. Eye Res. (1986) 43:829–847.
   PubMed Web of Science ®Google Scholar
• ELLIS EA, GUBERSKI DL, SOMOGYI-MANN M, GRANT MB: Increased H202, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Rad. Biol. Med. (2000) 28:91–101.
   PubMed Web of Science ®Google Scholar
• RUGGIERO D, LECOMTE M, MICHOUD E, LAGARDE M, WIERNSPERGER N: Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab. (1997) 23:30–42.
   PubMed Web of Science ®Google Scholar
• HO FM, LIU SH, LIAU CS, HUANG PJ, SHIAH SG, LIN-SHIAU SY: Nitric oxide prevents apoptosis of human endothelial cells from high glucose exposure during early stage.j Cell Biochem. (1999) 75:258–263.
   PubMed Web of Science ®Google Scholar
• MIRALLES C, BUSQUETS X, SANTOS C et al: Regulation of iNOS expression and glutathione levels in rat liver by oxygen tension. FEBS Lett. (2000) 476:253–257.
   PubMed Web of Science ®Google Scholar
• ROTH S: Role of nitric oxide in retinal cell death. Clin. Neurosci. 4:216–223 (1997)
   PubMedGoogle Scholar
• •An important role of nitric oxide in the pathogenesis of retinal ischaemic injury.
   Google Scholar
• SZABO C: DNA strand breakage and activation of poly-ADP ribotransferase: a cytotoxic pathway triggered by peroxynitrite. Free Rad. Biol. Med. (1996) 21:855–869.
   PubMed Web of Science ®Google Scholar
• BEHAR-COHEN FF, HEYDOLPH S FV, DROY-LEFAIX MT, COURTOIS Y, GOUREAU 0: Peroxynitrite cytotoxicity on bovine retinal pigmented epithelial cells in culture. Biochem. Biophys. Res. Commun. (1996) 226:842–849.
   PubMed Web of Science ®Google Scholar
• OATES PJ, MYLARI BL: Aldose reductase inhibitors: therapeutic implications for diabetic complications. Expert Opin. Investig. Drugs (1999) 8:2095–2119.
   PubMedGoogle Scholar
• BRAVI MC, PIETRANGELI P, LAURENTI 0 et al: Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metabolism (1997) 46:1194–1198.
   PubMed Web of Science ®Google Scholar
• STEVENS MJ, OBROS OVA I, CAO X, VAN HUYSEN C, GREENE DA: Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes (2000) 49:1006–1015.
   PubMed Web of Science ®Google Scholar
• TILTON RG, CHANG K, NYENGAARD JR, VAN DEN ENDEN M, IDO Y, WILLIAMSON JR: Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes (1995) 44:234–242.
   Google Scholar
• ROBISON WG, JR, NAGATA M, LAVER N, HOHMAN TC, KINOSHITA JH: Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthahnol. Vis. Sci. (1989) 30:2285–2292.
   PubMed Web of Science ®Google Scholar
• ENGERMAN RL, KERN TS: Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes (1993) 42:820–825.
   PubMed Web of Science ®Google Scholar
• SORBINIL RETINOPATHY TRIAL RESEARCH GROUP: A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch. Ophthalmol (1990) 108:1234–1244.
   PubMed Web of Science ®Google Scholar
• •Results of clinical trials showing that daily sorbinil administration for 3 years does not inhibit significantly the development of retinopathy in adult diabetic patients.
   Google Scholar
• VLASSARA H, STRIKER LJ, TEICHBERG S, FUH H, LI YM, STEFFES M: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc. Natl. Acad. Sci. USA (1994) 91:11704–11708.
   PubMed Web of Science ®Google Scholar
• ZIMMERMAN GA, MEISTRELL III M, BLOOM 0 et al.: Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. Proc. Natl. Acad. Li. USA (1995) 92:3744–3748.
   Google Scholar
• CHIBBER R, MOLINATTI PA, WONGJSK, MIRLESS D, KOHNER EM: The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes (1994) 43:758–763.
   PubMed Web of Science ®Google Scholar
• MORCOS M, BORCEA V, ISERMANN B et al: Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res. Pract. (2001) 52:175–183.
   PubMed Web of Science ®Google Scholar
• YAN SD, SCHMIDT AM, ANDERSON GM et al.: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. I Biol. Chem. (1994) 269:9889–9897.
   Web of Science ®Google Scholar
• CHAPPEY 0, DOSQUET C, WAUTIER MP, WAUTIER JL: Advanced glycation end product, oxidant stress and vascular lesions. Eur. Clin. Invest. (1997) 27:97–108.
   PubMed Web of Science ®Google Scholar
• NAKAMURA N, OBAYASHI H, FUJII M et al.: Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end products. Free Rad. Biol. Med. (2000) 29:17–25.
   PubMed Web of Science ®Google Scholar
• P1 CARD S, PARTHASARATHY S, FRUEBIS J, WIZTUM JL: Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors. Proc. Soc. Natl. Acad. Sri. USA (1991) 89:6876–6880.
   Google Scholar
• TILTON RG, CHANG K, HASAN KS et al.: Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes (1993) 42:221–232.
   Google Scholar
• KERN TS, TANG J, MIZUTANI M, KOWLURU R, NAGRAJ R, LORENZI M: Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia. Invest. Ophthalmol. Vis. Li. (2000) 41:3972–3978.
   PubMed Web of Science ®Google Scholar
• ••Evidence from animal study that thefrequency of early apoptosis in retinal microvascular cells can predict the development of the histologic lesions in diabetes.
   Google Scholar
• KOWLURU RA, ENGERMAN RL, KERN TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr. Eye Res. (2000) 21:814–819.
   PubMed Web of Science ®Google Scholar
• SHIBA T, INOGUCHI T, SPORTSMAN JR, HEATH WF, BURSELL S, KING GL: Correlation of diacylglycerol and protein kinase C in rat retina to retinal circulation. Am. j Physiol. (1993) 265:E783–E793.
   PubMed Web of Science ®Google Scholar
• SEN CK, SASHWATI R, PACKER L: Fas mediated apoptosis of human Jurkat T-cells: intracellular events and potentiation by redox-active alpha-lipoic acid. Cell. Death Differ (1999) 6:481–491.
   PubMed Web of Science ®Google Scholar
• PALUMBO EJ, SWEATT JD, CHEN S-J,KLANN E: Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. Biochem. Biophys. Res. Comm. (1992) 187:1438–1445.
   Web of Science ®Google Scholar
• STAUBLE B, BOSCOBOINIK D, TASINATO A, AZZI A: Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-a-tocopherol in vascular smooth muscles. Eur. j Biochem. (1994) 226:393–402.
   PubMedGoogle Scholar
• GOPALKRISHNA R, JANKEN S: Protein kinase C signalling and oxidative stress. Free Rad. Biol. Med. (2000) 28:1349–1361.
   PubMed Web of Science ®Google Scholar
• BURSELL SE, KING GL: Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? Diabetes Res. Clin. Pract. (1999) 45:169–182.
   Web of Science ®Google Scholar
• •Animal and clinical studies showing that high doses of vitamin E treatment can reverse some of the changes in the retinal vessels.
   Google Scholar
• HA H, YOON SJ, KIM KH: High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kid. Intl. (1994) 46:1620–1626.
   PubMed Web of Science ®Google Scholar
• KOWLURU RA, ENGERMAN RL, KERN TS: Oxidative stress and protein kinase C are inter-related in retinas of diabetic rats and galactose-fed rats. Diabetes (1997) 46\(Suppl. 1):9A.
   Google Scholar
• LEE IK, KOYA D, ISHI H, KANOH H, KING GL: D-a-tocopherol prevents the hyperglycemia induced activation of diacylglycerol protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. Diabetes Res. Clin. Pict. (1999) 45:183–190.
   PubMed Web of Science ®Google Scholar
• LUTTY GA, MCLEOD DS, MERGES C, DIGGS A, PLOUET J: Localization of vascular endothelial growth factor in human retina and choroid. Arch. Ophthal. (1996) 114:971–977.
   PubMed Web of Science ®Google Scholar
• LU M, KUROKI M, AMANO S et al.: Advanced glycation end products increase retinal vascular endothelial growth factor expression. j Clin. Invest. (1998) 101:1219–1224.
   PubMed Web of Science ®Google Scholar
• ENGERMAN RL, PFAFFENBACH D, DAVIS MD: Cell turnover of capillaries. Lab. Invest. (1967) 17:738–743.
   PubMed Web of Science ®Google Scholar
• MIZUTANI M, KERN TS, LORENZI M: Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. j Clin. Invest. (1996) 97:2883–2890.
   PubMed Web of Science ®Google Scholar
• •Evidence for the apoptosis of both endothelial cells and pericytes in diabetes.
   Google Scholar
• PODESTA F, ROMEO G, LIU WH, KRAJEWSKI S, REED JC, GERHARDINGER C, LORENZI M: Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am. j Pathol. (2000) 156:1025–1032.
   PubMed Web of Science ®Google Scholar
• CHEN H-Q, KOWLURU R: Antioxidants inhibit hyperglycemia-induced activation of caspase-3 in the retina (Abstract). Diabetes (2001) 50:A191.
   Web of Science ®Google Scholar
• RAFF MC, BARRES BA, BURNE JF, COLES HS, ISHIZAKI Y, JACOBSON MD: Programmed cell death and the control of cell survival: lessons from the nervous system. Science (1993) 262:695–700.
   PubMed Web of Science ®Google Scholar
• ROTH T, PODESTA E STEPP MA, BOERI D, LORENZI M: Integrin overexpression induced by high glucose and by human diabetes: Potential pathway to cell dysfunction in diabetic microangiopathy. Proc. Natl. Acad. Sci. USA (1993) 90:9640–9644.
   PubMed Web of Science ®Google Scholar
• BRESNICK G, ENGERMAN R, DAVIS MD, DE VENECIA G, MYERS FL: Patterns of ischemia in diabetic retinopathy. Trans. Am. Acad. Ophthalmol. Otolaryrigol. (1976) 81:694–709.
   Google Scholar
• STANGEL M, ZETTL UK, MIX E et al.: H202 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. j Neuropath. & Exp. Neural. (1996) 55:36–43.
   PubMed Web of Science ®Google Scholar
• KANNAN K, JAIN SK: Oxidative stress and apoptosis. Pathophysiology (2000) 7:153–163.
   PubMedGoogle Scholar
• •Overall review of oxidative stress and apoptosis.
   Google Scholar
• BAUGARTNER-PARZER SM, WAGNER L, PETTERMANN M, GRILLARI J, GESSL A, WALDHAUSL W: High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes (1995) 44:1323–1327.
   PubMed Web of Science ®Google Scholar
• ••High glucose results in apoptosis inendothelial cells.
   Google Scholar
• HAMPTON MB, ORRENIUS S: Redox regulation of apoptotic cell death in the immune system. Toxicology Lett. (1998) 102:355–358.
   PubMedGoogle Scholar
• MATSURA T, KAI M, FUJII Y, ITO H, YAMADA K: Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation. Free Rad. Res. (1999) 30:73–83.
   PubMed Web of Science ®Google Scholar
• HO FM, LIU SH, LIAU CS, HUANG PJ, LIN-SHIAU SY: High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation (2000) 101:2618–2624.
   PubMed Web of Science ®Google Scholar
• DEMURCIA G, HULETSKY A, POIRIER GG: Modulation of chromatin structure by poly ADP ribosylation. Biochem Cell Biology (1988) 66:626–635.
   PubMed Web of Science ®Google Scholar
• MEISTER A: Glutathione metabolism andits selective modification. J. Biol. Chem. (1988) 263:17205–17208.
   PubMed Web of Science ®Google Scholar
• SIES H, ARTEEL GE: Interaction of peroxynitrite with selenoproteins and glutathione peroxidase mimics. Free Rad. Biol. Med. (2000) 28:1451–1455.
   PubMed Web of Science ®Google Scholar
• YOUNG IS, TATE S, LIGHTBODY JH, MCMASTER D, TRIMBLE ER: The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Rad. Biol. Med. (1995) 18:833–840.
   PubMed Web of Science ®Google Scholar
• WINKLER BS, BOULTON ME, GOTTSCH JD, STERNBERG P: Oxidative damage and age-related macular degeneration. Ma. Vit. (1999) 5:32. 1675
   Google Scholar
• ALBERTINI R, ABUJA PM: Prooxidant and antioxidant properties of Trolox C, analogue of vitamin E, in oxidation of low-density lipoprotein. Free Rad. Res. (1999) 30:181–188.
   PubMed Web of Science ®Google Scholar
• PANASENKO OM, SHAROV VS, BRIVIBA K, SIES H: Interaction of peroxynitrite with carotenoids in human low density lipoproteins. Arch. Biochem. Biophys. (2000) 373:302–305.
   PubMed Web of Science ®Google Scholar
• PACKER L, TRITSCHLER HJ, WESSEL K: Neuroprotection by the metabolic antioxidant alpha lipoic acid. Free Rad. Biol. Med. (1997) 22:359–378.
   PubMed Web of Science ®Google Scholar
• GUO Q, PACKER L: Ascorbate-dependentrecycling of the vitamin E homologue Trolox by dihydrolipoate and glutathione in murine skin homogenates. Free Rad. Biol. Med. (2000) 29:368–374.
   PubMed Web of Science ®Google Scholar
• VAN ZANDWIJK N: N-acetylcysteine for lung cancer prevention. Chest (1995) 10:1437–1441.
   Google Scholar
• BROWN AA, HU FB: Dietary modulation of endothelial function: implications for cardiovascular disease. Am. j Gun. Num. (2001) 73:673–686.
   PubMed Web of Science ®Google Scholar
• KAUL N, SIVESKI-ILISKOVIC N, HILL M, KHAPER N, SENEVIRATNE C, SINGAL PK: Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol. Cell. Biochem. (1996) 160:283–288.
   PubMedGoogle Scholar
• AGARDH E, HULTBERG B, AGARDH C: Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. Curr. Eye Res. (2000) 21.
   Google Scholar
• LEVY Y, ZALTSBERG H, BEN-AMOTZ A, KANTER Y, AVIRAM M: Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus. Ann. Num. Metab. (2000) 44:54–60.
   PubMed Web of Science ®Google Scholar
• DEVARAJ S, JIALAL I: Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Rad. Biol Med. (2000) 29:790–792.
   PubMed Web of Science ®Google Scholar
• LONN E, YUSUF S, DZAVIK V, DORIS C, YI Q, SMITHS, MOORE-COX ASI: Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation (2001) 103:919–925.
   PubMed Web of Science ®Google Scholar
• KOWLURU RA, ENGERMAN RL, KERN TS: Diabetes-induced metabolic abnormalities in myocardium: Effect of antioxidant therapy. Free Rad. Res. (2000) 32:67–74.
   PubMed Web of Science ®Google Scholar
• DE MATTIA G, BRAVI MC, LAURENTI 0 et al: Reduction of oxidative stress by oral Nacetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes. Diabetologia (1998) 41:1392–1396.
   PubMed Web of Science ®Google Scholar
• CUNNINGHAM JJ, MEARKLE PL, BROWN RG: Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus. J. Am. Coll. Num. (1994) 13:344–350.
   PubMed Web of Science ®Google Scholar
• SAKAMAKI H, AKAZAWA S, ISHIBASHI M et al.: Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes (1999) 48:1138–1144.
   PubMed Web of Science ®Google Scholar
• WIZNITZER A, AYALON N, HERSHKOVITZ R et al: Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am. J. Obstet. Cynecol (1999) 180:188–193.
   PubMed Web of Science ®Google Scholar
• REDDI AS, BOLLINENI JS: Selenium-deficient diet induces renal oxidative stress and injury via TGF-betal in normal and diabetic rats. Kidney Int. (2001) 59:1342–1353.
   PubMed Web of Science ®Google Scholar
• MELHEM MF, CRAVEN PA, DERUBERTIS FR: Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J. Am. Soc. Nephrol (2001) 12:124–133.
   PubMed Web of Science ®Google Scholar
• RELJANOVIC M, REICHEL G, RETT K etal.: Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Rad. Res. (1999) 31:171–179.
   Google Scholar
• KARASU C, DEWHURST M, STEVENS EJ, TOMLISON DR: Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia (1995) 38:129–134.
   PubMed Web of Science ®Google Scholar
• NAGAMATSU M, NICKANDER SCHMELZER JD et al.: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care (1995) 18:1160–1167.
   Google Scholar
• CAMERON NE, COTTER MA: Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Gun. Pict. (1999) 45:137–146.
   PubMed Web of Science ®Google Scholar
• ECKHERT CD, LOCKWOOD MK, SHEN B: Influence of selenium on the microvasculature of the retina. ll/licrovasc. Res. (1993) 45:74–82
   PubMed Web of Science ®Google Scholar
• MURPHY TH, MIYAMOTO M, SASTRE A, SCHNAAR RL, COYLE JT: Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron (1989) 2(6):1547–1558.
   PubMed Web of Science ®Google Scholar
• KOWLURU RA, ENGERMAN RL, CASE GL, KERN TS: Retinal glutamate in diabetes and effect of antioxidants. Neurochem. mt. (2001) 38:385–390.
   PubMed Web of Science ®Google Scholar
• HAMMES HP, BARTMANN A, ENGEL L, WULFROTH P: Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia (1997) 40:629–634.
   PubMed Web of Science ®Google Scholar
• ANSARI NH, ZHANG W, FULEP E, MANSOUR A: Prevention of pericyte loss by Trolox in diabetic rat retina. _J. Taxied. Environ. Health (1998) 24:467–475.
   Google Scholar
• MAYER-DAVIS EJ, BELL RA, REBOUSSIN BA, RUSHING J, MARSHALL JA, HAMMAN RF: Antioxidant nutrient intake and diabetic retinopathy: the San Luis Vally diabetes study. Ophthalmology (1998) 105:2264–2270.
   PubMed Web of Science ®Google Scholar
• KNUDSEN CA, TAPPEL AL, NORTH JA: Multiple antioxidants protect against heme protein and lipid oxidation in kidney tissue. Free Rad. Biol. Med. (1996) 20:165–173.
   PubMed Web of Science ®Google Scholar
• ••Advantages of multi-antioxidant therapy. Affiliation
   Google Scholar